Solasia Pharma K.K. logo

Solasia Pharma K.K.

TSE:4597.T

Overview | Financials
Company Name Solasia Pharma K.K.
Symbol 4597.T
Currency JPY
Price 46
Market Cap 10,016,954,940
Dividend Yield 0%
52-week-range 23 - 71
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Yoshihiro Arai
Website https://www.solasia.co.jp

An error occurred while fetching data.

About Solasia Pharma K.K.

Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery

Related Stocks

SEED Co.,Ltd. logo

SEED Co.,Ltd.

7743.T

495 JPY

JTEC Corporation logo

JTEC Corporation

3446.T

1,695 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,393 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

300 JPY

MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370.T

42 JPY

OncoTherapy Science, Inc. logo

OncoTherapy Science, Inc.

4564.T

32 JPY

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,800 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

408 JPY

OLBA HEALTHCARE HOLDINGS, Inc. logo

OLBA HEALTHCARE HOLDINGS, Inc.

2689.T

1,983 JPY

DVx Inc. logo

DVx Inc.

3079.T

913 JPY

Financials

Numbers are in millions USD

Numbers are in millions USD